As almost 75% of US adults are overweight or obese, the US Food and Drug Administration has announced a simple, mandatory ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

Regular walking, even in small amounts, can greatly enhance longevity and overall health, according to recent studies ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Effective management of type 2 diabetes often requires a combination of medication, regular physical activity, changes in diet, weight loss, and blood sugar monitoring. Research has also suggested ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

Sotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular ...

The rise in human life expectancy has slowed down across Europe since 2011, according to new research. A new study reveals that the food we eat, physical inactivity and obesity are largely to blame, ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

A recently approved drug has shown promise in reducing heart attacks and strokes in patients with type 2 diabetes and kidney disease. This medication, a sodium-glucose cotransporter (SGLT) inhibitor, ...